The 2026 TV Drug Ad-Spend Report
A June 2026 snapshot of TVPills internal editorial estimates of annual TV advertising budgets. These figures are not realized full-year 2026 spending or year-to-date totals.
$13.0B
Internal editorial estimate, not actual spend
144
Drugs with positive estimated TV budgets
Humira
$500M / yr
Autoimmune
Largest estimated annual budget by condition
Across 144 tracked medications, TVPills' internal editorial estimates of annual TV ad budgets total $13.0B. This dated snapshot is not measured 2026 or year-to-date spending. AbbVie ranks first in these estimates at $1.9B across 13 brands. The average tracked drug carries a $90M estimated annual budget.
Estimated budgets by manufacturer
Internal editorial estimates of annual TV ad budgets grouped by manufacturer; not measured spending.
Estimated budgets by condition
Internal editorial estimates of annual TV ad budgets grouped by condition; not measured spending.
By country
Annual budget estimates for tracked records, not measured country spending. The US and New Zealand allow consumer product-claim ads; Canada restricts consumer messages to reminder ads or help-seeking messages. Health Canada advertising guidance. These estimates cannot establish whether regulations explain differences between the country totals.
The 10 largest estimated annual budgets
Largest internal editorial estimates of annual TV ad budgets in this 2026 snapshot, not measured spend during the period.
- 1$500MAnnual est. · catalogue record
Humira US
AbbVie · Rheumatoid arthritis, psoriasis, Crohn's disease
- 2$480MAnnual est. · catalogue record
Skyrizi US
AbbVie · Plaque psoriasis, psoriatic arthritis, Crohn's disease
- 3$420MAnnual est. · catalogue record
Ozempic US
Novo Nordisk · Type 2 diabetes
- 4$390MAnnual est. · catalogue record
Dupixent US
Sanofi/Regeneron · Eczema, asthma, nasal polyps, COPD
- 5$380MAnnual est. · catalogue record
Wegovy US
Novo Nordisk · Chronic weight management, cardiovascular risk reduction
- 6$350MAnnual est. · catalogue record
Mounjaro US
Eli Lilly · Type 2 diabetes
- 7$350MAnnual est. · catalogue record
Eliquis US
Bristol-Myers Squibb/Pfizer · Blood clots, atrial fibrillation
- 8$300MAnnual est. · catalogue record
Zepbound US
Eli Lilly · Chronic weight management, obstructive sleep apnea
- 9$280MAnnual est. · catalogue record
Jardiance US
Boehringer Ingelheim/Eli Lilly · Type 2 diabetes, heart failure, chronic kidney disease
- 10$260MAnnual est. · catalogue record
Keytruda US
Merck · Multiple cancers
TV drug ad spend: frequently asked questions
What annual TV ad budgets does TVPills estimate in its 2026 snapshot?
Across the 144 TV-advertised prescription drugs we track in the US, Canada, and New Zealand, TVPills' internal editorial estimates of annual TV ad budgets total $13.0B — an average of about $90M per advertised drug. These are not realized 2026 or year-to-date spending figures.
Which tracked drug has the largest estimated annual TV ad budget?
Humira carries the single largest estimated TV ad budget at about $500M a year in our 2026 snapshot of internal editorial estimates, not measured ad spending.
Which manufacturer has the largest estimated annual TV ad budget?
AbbVie ranks first in our internal editorial estimates, totaling $1.9B in annual TV ad budgets across 13 brands in our tracked catalogue.
Which health conditions have the largest estimated TV ad budgets?
Autoimmune, Diabetes, Cardiovascular lead our internal annual TV ad budget estimates, with Autoimmune ranking first among the conditions we track.
Which countries allow prescription drug ads on TV?
The United States and New Zealand allow consumer product-claim ads that name prescription drugs and describe their uses. Canada restricts consumer messages to reminder ads (drug name, price and quantity without a disease claim) or help-seeking messages (disease information without naming a drug). Health Canada guidance is linked on this page. Country totals in this report are sums of internal editorial estimates for tracked records, not measured national TV ad spending or evidence that regulations caused the differences.
Canadian advertising rules: Health Canada’s prescription-drug advertising guidance.
More editions
Sources & methodology
Source dataset: TVPills maintained drug catalogue (TVPills Editorial Team). The catalogue snapshot used for these figures was retrieved June 30, 2026.
Calculation: Each drug record's tvAdBudgetMillions value is treated as an estimated annual budget in millions of US dollars. Rankings sort records descending by that value; totals and group totals sum each positive record once, without weighting or extrapolating from commercial counts. Each individual amount in the rankings links to the corresponding catalogue record; grouped totals use the same record-level values.
Limitations: These values are editorial estimates, not company-reported or independently audited media-buying figures. The catalogue does not currently attach a public third-party publication to each estimate, so the figures should not be used as financial, investment, or market-size data.
Source status: Internal editorial estimate. No company filing or independent media-buying dataset is being presented as the source for these values.
Embed this report
Writing about drug advertising? This live widget uses current catalogue estimates, not this dated report snapshot. Please keep the credit link and identify the figures as internal editorial estimates of annual budgets, not measured spending.
Cite this data
Quoting a figure from this report? Identify it as an internal editorial estimate of an annual budget from a dated snapshot, not measured spending. Please credit TVPills with a link back.